Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Manual Lymphatic Drainage Versus Classical Massage on Heart Responses and Mood in Hemodialysis

6 novembre 2026 aggiornato da: Melike Davarcı, Mersin University

Acute Effects of Manual Lymphatic Drainage and Classical Massage on Cardiovascular and Autonomic Responses and Mood in Patients Undergoing Hemodialysis: A Randomized Controlled Crossover Experimental Study

The goal of this randomized controlled crossover trial is to learn whether manual lymphatic drainage (MLD) and classical massage have different short-term effects on the heart, the nervous system, and mood in adults aged 18 to 65 receiving hemodialysis. A total of 60 patients from two hemodialysis centers in Tarsus, Mersin, Türkiye, are planned to take part.

The main questions it aims to answer are:

  • Do MLD and classical massage differ in their short-term effects on autonomic nervous system responses, measured by heart rate variability (SDNN, RMSSD, LF, HF, LF/HF)? (Primary hypothesis 1)
  • Do MLD and classical massage differ in their short-term effects on cardiovascular responses, measured by systolic and diastolic blood pressure and heart rate? (Primary hypothesis 2)
  • Do MLD and classical massage differ in their short-term effects on mood (fatigue, vigor, tension, and confusion), measured by the Profile of Mood States - Short Form? (Secondary hypothesis)

Researchers will compare MLD with classical massage (active comparator). Each participant will receive both massages in a randomly assigned order (MLD first or classical massage first), so each participant serves as their own control. In addition, a no-massage control measurement will be taken in the week before the massages to show the changes caused by the hemodialysis session alone.

Participants will:

  • In the first week (control period), have their blood pressure, heart rate, and heart rate variability measured three times during a hemodialysis session without any massage.
  • In the second week, receive a 20-minute MLD or classical massage on both legs (thigh, lower leg, and foot), starting one hour after the beginning of the hemodialysis session.
  • After a one-week break (washout period), receive the other type of massage in the same way.
  • Have their blood pressure, heart rate, and heart rate variability measured before each massage, right after it, and 30 minutes later. Heart rate variability will be recorded for 5 minutes with a chest strap.
  • Complete a short mood questionnaire.

Panoramica dello studio

Descrizione dettagliata

Cardiovascular disease is the leading cause of death in patients receiving hemodialysis (HD), accounting for about half of all deaths in this group. Blood pressure variability during dialysis is closely linked to cardiovascular events, and autonomic imbalance contributes to complications such as intradialytic hypotension and hypertension, each affecting about 15% of patients. Heart rate variability (HRV) is a non-invasive indicator of cardiac autonomic regulation and is reduced in chronic kidney disease. In addition, anxiety and depressive symptoms are common in HD patients and are associated with lower quality of life. Therefore, cardiovascular, autonomic, and emotional responses should be considered together during HD.

Massage is a low-cost, easy-to-apply, non-invasive nursing intervention with a low risk of serious side effects. Mechanical stimulation of the skin, muscle, and fascia may influence autonomic nervous system activity. Manual lymphatic drainage (MLD) is a technique that uses light, slow, rhythmic pressure to support lymphatic flow and has been associated with parasympathetic activation and relaxation. However, evidence on the cardiovascular and autonomic effects of MLD is limited, and its acute effects when applied during HD have not been studied.

Aim

The aim of this study is to evaluate and compare the acute cardiovascular, autonomic, and mood effects of 20-minute MLD and 20-minute classical massage applied during hemodialysis. The study is expected to help identify manual techniques that support cardiovascular and autonomic balance and to contribute to the development of evidence-based, non-pharmacological nursing interventions for HD care.

Originality

Previous massage studies in HD patients have mainly focused on symptoms and quality of life, such as fatigue, restless legs syndrome, muscle cramps, and sleep quality. Studies on the autonomic effects of MLD have mostly been conducted in healthy or stressed individuals. To the investigators' knowledge, no study has directly compared MLD and classical massage in terms of acute cardiovascular and autonomic responses in HD patients. This study is original in that:

  • It evaluates HRV together with blood pressure and heart rate, allowing a multidimensional assessment of the acute physiological responses to two manual techniques during HD.
  • It assesses acute changes in mood within a single dialysis session, whereas previous studies have focused on long-term psychological outcomes.
  • It uses a crossover design in which each participant receives both interventions and serves as their own control, which reduces between-subject variability and increases statistical power.
  • The interventions are applied during the dialysis session and can be integrated into routine care without adding extra time burden for patients.

Hypotheses

In hemodialysis patients, the effects of 20-minute MLD and 20-minute classical massage:

  • Primary Hypothesis 1 (H1): differ in terms of acute autonomic responses (HRV).
  • Primary Hypothesis 2 (H2): differ in terms of acute cardiovascular responses (systolic and diastolic blood pressure, heart rate).
  • Secondary Hypothesis (H3): differ in terms of acute mood.

Methods

Design: Two-period, two-sequence (AB/BA), randomized controlled crossover study.

Participants: Patients aged 18 to 65 years who have received HD for at least three months, three times a week, about four hours per session. Main exclusion criteria are conditions preventing massage (e.g., foot ulcer, amputation, orthopedic problems), cancer, chronic respiratory failure, heart failure, rheumatoid arthritis, lupus, diagnosed psychiatric illness, use of sleeping pills or sedatives, atrial fibrillation, and pacemaker use.

Tipo di studio

Interventistico

Iscrizione (Stimato)

60

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Luoghi di studio

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

Da 18 anni a 65 anni (Adulto, Adulto più anziano)

Accetta volontari sani

No

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria:

  • Being between 18 and 65 years of age
  • Having received hemodialysis treatment for at least three months
  • Receiving hemodialysis treatment at least three times a week, each session lasting approximately four hours
  • Volunteering to participate in the study and providing written informed consent

Exclusion Criteria:

  • Having a medical condition that would prevent the intervention, such as a foot ulcer, amputation, or an orthopedic problem
  • Having a chronic disease such as cancer, chronic respiratory failure, heart failure, rheumatoid arthritis, or lupus erythematosus
  • Having been diagnosed with a psychiatric illness such as depression or bipolar disorder
  • Having a history of a pathological condition, injury, or surgical procedure that would prevent the intervention from being performed safely
  • Using sleeping pills or sedatives, as these may affect autonomic responses and HRV measurements
  • Having a history of atrial fibrillation or having a pacemaker

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Terapia di supporto
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione incrociata
  • Mascheramento: Separare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: MLD then Classical Massage (AB)

Participants will undergo a no-intervention control measurement (Z0), then receive 20 minutes of manual lymphatic drainage on both lower extremities during hemodialysis in Period 1, and after a one-week washout period, 20 minutes of classical massage in Period 2.

20-minute MLD applied to both lower extremities (thigh, lower leg, and foot) one hour after the start of the hemodialysis session, using light, slow, rhythmic, superficial stroking, pumping, circular, and rotary maneuvers directed toward the inguinal, popliteal, and medial malleolar lymphatic regions.

20-minute classical massage applied to both lower extremities (thigh, lower leg, and foot) one hour after the start of the hemodialysis session, using effleurage, petrissage, and friction, beginning and ending with effleurage.

Sperimentale: Classical Massage then MLD (BA)

Participants will undergo a no-intervention control measurement (Z0), then receive 20 minutes of classical massage on both lower extremities during hemodialysis in Period 1, and after a one-week washout period, 20 minutes of manual lymphatic drainage in Period 2.

20-minute MLD applied to both lower extremities (thigh, lower leg, and foot) one hour after the start of the hemodialysis session, using light, slow, rhythmic, superficial stroking, pumping, circular, and rotary maneuvers directed toward the inguinal, popliteal, and medial malleolar lymphatic regions.

20-minute classical massage applied to both lower extremities (thigh, lower leg, and foot) one hour after the start of the hemodialysis session, using effleurage, petrissage, and friction, beginning and ending with effleurage.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Lasso di tempo
Standard Deviation of Normal-to-Normal Intervals (SDNN)
Lasso di tempo: Before the intervention, immediately after the 20-minute intervention, and 30 minutes after the post-intervention measurement, in each period
Before the intervention, immediately after the 20-minute intervention, and 30 minutes after the post-intervention measurement, in each period
Root Mean Square of Successive Differences (RMSSD)
Lasso di tempo: Before the intervention, immediately after the 20-minute intervention, and 30 minutes after the post-intervention measurement, in each period
Before the intervention, immediately after the 20-minute intervention, and 30 minutes after the post-intervention measurement, in each period
Low Frequency (LF) Power
Lasso di tempo: Before the intervention, immediately after the 20-minute intervention, and 30 minutes after the post-intervention measurement, in each period
Before the intervention, immediately after the 20-minute intervention, and 30 minutes after the post-intervention measurement, in each period
High Frequency (HF) Power
Lasso di tempo: Before the intervention, immediately after the 20-minute intervention, and 30 minutes after the post-intervention measurement, in each period
Before the intervention, immediately after the 20-minute intervention, and 30 minutes after the post-intervention measurement, in each period
Low Frequency to High Frequency Ratio (LF/HF)
Lasso di tempo: Before the intervention, immediately after the 20-minute intervention, and 30 minutes after the post-intervention measurement, in each period
Before the intervention, immediately after the 20-minute intervention, and 30 minutes after the post-intervention measurement, in each period
Systolic Blood Pressure
Lasso di tempo: Before the intervention, immediately after the 20-minute intervention, and 30 minutes after the post-intervention measurement, in each period
Before the intervention, immediately after the 20-minute intervention, and 30 minutes after the post-intervention measurement, in each period
Diastolic Blood Pressure
Lasso di tempo: Before the intervention, immediately after the 20-minute intervention, and 30 minutes after the post-intervention measurement, in each period
Before the intervention, immediately after the 20-minute intervention, and 30 minutes after the post-intervention measurement, in each period
Heart Rate
Lasso di tempo: Before the intervention, immediately after the 20-minute intervention, and 30 minutes after the post-intervention measurement, in each period
Before the intervention, immediately after the 20-minute intervention, and 30 minutes after the post-intervention measurement, in each period

Misure di risultato secondarie

Misura del risultato
Lasso di tempo
Fatigue Subscale Score of the Profile of Mood States - Short Form
Lasso di tempo: Before and immediately after the 20-minute intervention, in each intervention period
Before and immediately after the 20-minute intervention, in each intervention period
Vigor Subscale Score of the Profile of Mood States - Short Form
Lasso di tempo: Before and immediately after the 20-minute intervention, in each intervention period
Before and immediately after the 20-minute intervention, in each intervention period
Tension Subscale Score of the Profile of Mood States - Short Form
Lasso di tempo: Before and immediately after the 20-minute intervention, in each intervention period
Before and immediately after the 20-minute intervention, in each intervention period
Confusion Subscale Score of the Profile of Mood States - Short Form
Lasso di tempo: Before and immediately after the 20-minute intervention, in each intervention period
Before and immediately after the 20-minute intervention, in each intervention period

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

24 novembre 2026

Completamento primario (Stimato)

24 novembre 2026

Completamento dello studio (Stimato)

30 settembre 2027

Date di iscrizione allo studio

Primo inviato

6 novembre 2026

Primo inviato che soddisfa i criteri di controllo qualità

6 novembre 2026

Primo Inserito (Effettivo)

12 novembre 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

12 novembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

6 novembre 2026

Ultimo verificato

1 novembre 2026

Maggiori informazioni

Termini relativi a questo studio

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

SÌ

Tipo di informazioni di supporto alla condivisione IPD

  • STUDIO_PROTOCOLLO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi